Submit Your Feeds

Business News • PR NewsWire • Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections

Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections
Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections

LAUSANNE, Switzerland, April 23, 2015 /PRNewswire/ -- Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the...

View More : http://www.prnewswire.com/news-releases/debiopharm-international-sa-initiates-clinical-phase-ii-study-evaluating-debio-1...
Releted News by prnewswire
Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections
Backbone Solutions AG lanza virtual-server.net
Backbone Solutions AG lance virtual-server.net
Nano Terra Receives Boeing Performance Excellence Award
Home Sitemap Contact Us
© businessNewsNewsNews.com